PHAGE BANK

APT is putting out a challenge to the AMR clinical research community: can you find a bacteria that our phage bank does not cover? We are confident that we either currently cover all bacterial isolates or can expand coverage to include any isolate within 120 days... We guarantee that APT's phage bank will demonstrate sensitivity on any ESKAPE* AMR isolate or we will pay the individual or institution that provided the isolate $1,000... APT's phage bank, in combination with our Phage Susceptibility Test (PST), closes the loop in antibiotic development, breaking the failed cycle of repeated antibiotic product introduction followed by resistance-driven obsolescence. Unlike traditional antibiotic development, APT's phage bank approach is designed to adapt to emerging resistance within weeks. With the combination of the world's largest and most diverse therapeutic phage collection and the integration of real-time surveillance of phage susceptibility, gaps in antibiotic spectrum are now..